β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model

Anna Laura Nelson,Chiara Mancino,Xueqin Gao,Joshua A. Choe,Laura Chubb,Katherine Williams,Molly Czachor,Ralph Marcucio,Francesca Taraballi,John P. Cooke,Johnny Huard,Chelsea Bahney,Nicole Ehrhart
DOI: https://doi.org/10.1016/j.bioactmat.2024.05.020
IF: 18.9
2024-05-25
Bioactive Materials
Abstract:Highlights • SM-102 LNPs enhanced transfection in vitro and prolonged transfection in vivo. • SM-102 LNPs did not alter osteogenesis or promote inflammation in the fracture. • β-catenin mRNA demonstrated bioactivity in vitro. • β-catenin mRNA increased bone formation in the fracture callus. Fractures continue to be a global economic burden as there are currently no osteoanabolic drugs approved to accelerate fracture healing. In this study, we aimed to develop an osteoanabolic therapy which activates the Wnt/β-catenin pathway, a molecular driver of endochondral ossification. We hypothesize that using an mRNA-based therapeutic encoding β-catenin could promote cartilage to bone transformation formation by activating the canonical Wnt signaling pathway in chondrocytes. To optimize a delivery platform built on recent advancements in liposomal technologies, two FDA-approved ionizable phospholipids, DLin-MC3-DMA (MC3) and SM-102, were used to fabricate unique ionizable lipid nanoparticle (LNP) formulations and then tested for transfection efficacy both in vitro and in a murine tibia fracture model. Using firefly luciferase mRNA as a reporter gene to track and quantify transfection, SM-102 LNPs showed enhanced transfection efficacy in vitro and prolonged transfection, minimal fracture interference and no localized inflammatory response in vivo over MC3 LNPs. The generated β-catenin GOF mRNA encapsulated in SM-102 LNPs (SM-102-β-catenin GOF mRNA) showed bioactivity in vitro through upregulation of downstream canonical Wnt genes, axin2 and runx2 . When testing SM-102-β-catenin GOF mRNA therapeutic in a murine tibia fracture model, histomorphometric analysis showed increased bone and decreased cartilage composition with the 45 μg concentration at 2 weeks post-fracture. μCT testing confirmed that SM-102-β-catenin GOF mRNA promoted bone formation in vivo , revealing significantly more bone volume over total volume in the 45 μg group. Thus, we generated a novel mRNA-based therapeutic encoding a β-catenin mRNA and optimized an SM-102-based LNP to maximize transfection efficacy with a localized delivery. Graphical abstract Download : Download high-res image (484KB) Download : Download full-size image
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?